NanoString Blog
Category: Oncology
Oncology
From an Egyptian Papyrus to the Hallmarks of Cancer: A Journey through the Development of Knowledge in Oncology Research
The word “cancer” was used for the first time in ancient Greece by Hippocrates, often termed the Father of Medicine for his contributions to modern medical practice. Even prior to…
Oncology
Statistically Significant Results without the Headache. Q&A with Sarah Church, Ph.D., Senior Scientist at NanoString.
Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString and one of the warmest people…
Oncology
Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.
Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…
Immunology Oncology
Why is Spatial Transcriptomics Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D
“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and…
Oncology
Top Ten Challenges in Cancer Immunology & Immunotherapy
Cancer immunotherapy (CIT) research and investments have progressed in the past few years thanks to its successful application across a…
Autoimmunity Digital Spatial Profiling Neuroscience Oncology
Readers’ Favorite Webinars: A Year in Review
NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions. They have always been a crowd-pleaser,…
Oncology
Immunotherapy in Tumors: Integrated Information to Outsmart Cancer
If it wasn’t such a devastating disease, there would be memes about how super-smart cancer is. Cancer cells can express neoantigens — tumor-specific, mutated peptides — that, when processed and…
Oncology
A Transcriptomic Solution Customized for Your Every Need
The flexibility of the NanoString nCounter® platform has been designed to accommodate a wide range of organisms, molecular targets, and sample inputs. Researchers can request “made-to-order” Custom CodeSets for up…
Digital Spatial Profiling Miscellaneous Oncology
Meet NanoString Scientists at the AMP 2019 Annual Meeting & Expo
When Elaine Lyon, Ph.D., a scientist on the board of the Association for Molecular Pathology (AMP) was asked why she is involved with AMP, its activities and initiatives, she quoted…
Oncology
Top Challenges of Biofluid Samples when Profiling FFPE miRNA Biomarkers
In 1993, Dr. Victor Ambros’ lab discovered a small RNA sequence, Lin-4, that was “essential for the normal temporal control of diverse postembryonic developmental events in C. Elegans”. Sequence analysis…
Oncology
The bench side of organ transplant: Challenges and solutions
“It is infinitely better to transplant a heart than bury it to be devoured by worms,” said Dr. Christiaan Barnard, the father of the heart transplant. It’s hard to disagree…
Oncology
Aiming at the Achilles’ heel of cancer: multiplexed lung cancer fusion detection without FISH or NGS
Lung cancer is the most commonly diagnosed cancer worldwide, and the leading cause of cancer deaths in the United States. It is generally divided into two types, non-small cell lung…